Search by Drug Name or NDC

    NDC 29300-0296-01 Ranolazine 500 mg/1 Details

    Ranolazine 500 mg/1

    Ranolazine is a ORAL TABLET, FILM COATED, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Unichem Pharmaceuticals (USA), Inc.. The primary component is RANOLAZINE.

    Product Information

    NDC 29300-0296
    Product ID 29300-296_429d55c7-1e90-4345-a6d4-59f689557f40
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Ranolazine
    Proprietary Name Suffix n/a
    Non-Proprietary Name Ranolazine
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, FILM COATED, EXTENDED RELEASE
    Route ORAL
    Active Ingredient Strength 500
    Active Ingredient Units mg/1
    Substance Name RANOLAZINE
    Labeler Name Unichem Pharmaceuticals (USA), Inc.
    Pharmaceutical Class Anti-anginal [EPC], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA213083
    Listing Certified Through 2024-12-31

    Package

    NDC 29300-0296-01 (29300029601)

    NDC Package Code 29300-296-01
    Billing NDC 29300029601
    Package 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (29300-296-01)
    Marketing Start Date 2023-07-15
    NDC Exclude Flag N
    Pricing Information N/A